LYEL
Lyell Immunopharma·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
LYEL fundamentals
Lyell Immunopharma (LYEL) released its earnings on Aug 12, 2025: revenue was 8.00K (YoY -38.46%), beat estimates; EPS was -3.67 (YoY -1938.89%), missed estimates.
Revenue / YoY
8.00K
-38.46%
EPS / YoY
-3.67
-1938.89%
Report date
Aug 12, 2025
Earnings Call
4:00 PM on Aug 12, 2025
Meeting link.EPS
Revenue
Revenue & Expenses
LYEL has released its 2025 Q3 earnings report, with revenue of 15.00K, reflecting a YoY change of -55.88%, and net profit of -38.85M, showing a YoY change of 12.87%. The Sankey diagram below clearly presents LYEL's revenue sources and cost distribution.
Key Indicators
Lyell Immunopharma (LYEL) key financial stats and ratios, covering profitability, financial health, and leverage.
Lyell Immunopharma (LYEL)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Lyell Immunopharma (LYEL)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Lyell Immunopharma (LYEL)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Lyell Immunopharma (LYEL) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Lyell Immunopharma (LYEL) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is the revenue and EPS growth rate for Lyell Immunopharma year over year?What is Lyell Immunopharma's gross profit margin?What were the key takeaways from Lyell Immunopharma's earnings call?What were the key takeaways from Lyell Immunopharma’s earnings call?What factors drove the changes in Lyell Immunopharma's revenue and profit?Did Lyell Immunopharma beat or miss consensus estimates last quarter?What does Lyell Immunopharma do and what are its main business segments?What is the market's earnings forecast for Lyell Immunopharma next quarter?
